Terumo to Establish 'DX Promotion Department' for Accelerating Group-wide Digital Transformation

Dự đoán xổ số xoa dịuFebruary 4, 2021

TOKYO, JAPAN - February 4, 2021 - Terumo Corporation (TSE: 4543) today announced that it will establish the 'DX Promotion Department' on April 1, 2021.

The DX Promotion Department will design a digital transformation (DX) strategy for the entire Terumo Group. It aims to drive "DX for business creation" that will heighten value proposition to customers, and expedite "DX for operation" to increase efficiency and level up the company's value chain.

Over the years, Terumo has worked on various projects that utilize digital technology, such as pharmaceutical infusion pumps linked with hospital IT systemsDự đoán xổ số xoa dịu and platforms to support heart disease treatments. The company has also advanced digitalization in its operations such as the global integration of ERP systems.

By establishing the new organization, Terumo will strive to achieve further growth, through transformation in both business creation and operation from a Group-wide perspective.

About Terumo

Dự đoán xổ số xoa dịuTerumo (TSE: 4543) is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare" for 100 years. Based in Tokyo and operating globally, Terumo employs more than 25,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technologies, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.

Media Contact

Dự đoán xổ số xoa dịuCorporate Communication Dept., Terumo Corporation

Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not intended to be guarantees of future events or performance. Accordingly, it should be noted that actual results may differ from those forecasts or projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition.

Information about products (including products currently in development) included in this material is not intended to constitute an advertisement or medical advice.

Print
T
O
P